Asymmetrical Si rhodamine and rhodol synthesis

US9714260B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9714260-B2
Application numberUS-201414759306-A
CountryUS
Kind codeB2
Filing dateJan 7, 2014
Priority dateJan 7, 2013
Publication dateJul 25, 2017
Grant dateJul 25, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

[Problem] To provide: a compound resulting from substituting with a silicon atom the oxygen atom at position 10 of a xanthene ring site of a rhodamine of which amino groups at position 3 and position 6 have an asymmetrical structure; a method for producing the compound; and a fluorescent probe that uses the compound. [Solution] The compound represented by general formula (I) or a salt thereof.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of formula (I) below or a salt thereof where: R 1 is a hydrogen atom or 1-4 of the same or different monovalent substituents present on a benzene ring; R 2 is a monovalent substituent; R 3 and R 4 are, each independently, a hydrogen atom, C 1-6 alkyl group, or halogen atom; R 5 and R 6 are, each independently, a C 1-6 alkyl group or aryl group; R 7 and R 8 are, each independently, a hydrogen atom, C 1-6 alkyl group, or halogen atom; R 9 and R 10 are, each independently, a hydrogen atom, C 1-6 alkyl group, or monovalent substituent cleaved by contact with a measured substance; R 9 or R 10 optionally forms, together with R 3 or R 7 , a 5-7-member heterocyclyl or heteroaryl containing a nitrogen atom to which R 9 or R 10 binds, and optionally contains 1-3 additional heteroatoms selected from the group consisting of oxygen atoms, nitrogen atoms, and sulfur atoms as ring-constituting members; the heterocyclyl or heteroaryl optionally being substituted by a C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 6-10 aralkyl, or C 6-10 alkyl-substituted alkenyl group; Y is selected from (1) NR 11 R 12 (2) OR 13 or (3) —N═N—R 14 where: R 11 is a hydrogen atom, C 1-6 alkyl group, or monovalent substituent cleaved by contact with a measured substance; R 12 is a hydrogen atom, C 1-6 alkyl group, or acyl group; R 11 and R 12 optionally form a 5-7-member heterocyclyl containing a nitrogen atom to which R 11 and R 12 bind, and optionally contain 1-3 additional heteroatoms selected from the group consisting of oxygen atoms, nitrogen atoms, and sulfur atoms as ring-constituting members; the heterocyclyl optionally being substituted by a C 1-6 alkyl group; R 13 is a hydrogen atom or monovalent substituent cleaved by contact with a measured substance; and R 14 is an aryl group; and X is a silicon, germanium, or tin atom; when Y is —NR 11 R 12 , (i) R 9 and R 10 are not monovalent substituents cleaved by contact with a measured substance, and (ii) at least one of R 9 and R 10 differs from at least one of R 11 and R 12 ; provided that a compound wherein R 9 and R 10 are hydrogen, R 12 is a hydrogen, and R 11 is a monovalent substituent cleaved by contact with a measured substance, is excluded; when Y is —OR 13 and R 13 is a hydrogen atom, R 9 or R 10 is optionally a monovalent substituent cleaved by contact with a measured substance; and when Y is —N═N—R 14 , R 9 and R 10 are not a monovalent substituent cleaved by contact with a measured substance. 2. The compound or salt thereof according to claim 1 having the structure of formula (Ia) below, Y being —NR 11 R 12 where: R 1 to R 12 and X are as defined in formula (I), but (i) R 9 and R 10 are not monovalent substituents cleaved by contact with a measured substance, and (ii) when R 11 and R 12 are hydrogen atoms, R 9 and R 10 are not both hydrogen atoms. 3. The compound or salt thereof according to claim 2 , wherein R 9 or R 10 forms, together with R 3 or R 7 , a 5-7-member heterocyclyl or heteroaryl containing a nitrogen atom to which R 9 or R 10 binds; wherein the heterocyclyl or heteroaryl optionally contains 1-3 additional heteroatoms selected from the group consisting of oxygen atoms, nitrogen atoms, and sulfur atoms as ring-constituting members; the heterocyclyl or heteroaryl optionally being substituted by a C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 6-10 aralkyl group, or C 6-10 alkyl-substituted alkenyl group. 4. The compound or salt thereof according to claim 3 , wherein R 9 forms, together with R 3 , a 5-7-member heterocyclyl or heteroaryl containing a nitrogen atom to which R 9 binds. 5. The compound or salt thereof according to claim 4 , having the structure of formula (Ia-1) below where R 1 -R 2 , R 4 -R 8 , R 10 -R 12 , and X are as defined in formula (Ia). 6. The compound or salt thereof according to claim 2 , wherein R 11 and R 12 form a 5-7-member heterocyclyl containing a nitrogen atom to which R 11 and R 12 bind; wherein the heterocyclyl optionally contains 1-3 additional heteroatoms selected from the group consisting of oxygen atoms, nitrogen atoms, and sulfur atoms as ring-constituting members; the heterocyclyl optionally being substituted by a C 1-6 alkyl group. 7. A compound of formula (Ia) below or a salt thereof where: R 1 is a hydrogen atom or 1-4 of the same or different monovalent substituents present on a benzene ring; R 2 is a monovalent substituent; R 3 and R 4 are, each independently, a hydrogen atom, C 1-6 alkyl group, or halogen atom; R 5 and R 6 are, each independently, a C 1-6 alkyl group or aryl group; R 7 and R 8 are, each independently, a hydrogen atom, C 1-6 alkyl group, or halogen atom; R 9 and R 10 are, each independently, a hydrogen atom, C 1-6 alkyl group, or monovalent substituent cleaved by contact with a measured substance; R 9 or R 10 optionally forms, together with R 3 or R 7 , a 5-7-member heterocyclyl or heteroaryl containing a nitrogen atom to which R 9 or R 10 binds, and optionally contains 1-3 additional heteroatoms selected from the group consisting of oxygen atoms, nitrogen atoms, and sulfur atoms as ring-constituting members; the heterocyclyl or heteroaryl optionally being substituted by a C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 6-10 aralkyl, or C 6-10 alkyl-substituted alkenyl group; X is a silicon, germanium, or tin atom; R 9 and R 10 are not monovalent substituents cleaved by contact with a measured substance; and R 11 and R 12 form a piperazine ring together with a nitrogen atom to which R 11 and R 12 bind. 8. The compound or salt thereof according to claim 7 , having the structure of formula (Ia-2) below where R 1 -R 10 and X are as defined in formula (Ia), and R 15 is a C 1-6 alkyl group. 9. A compound of formula (I) below or a salt thereof where: R 1 is a hydrogen atom or 1-4 of the same or different monovalent substituents present on a benzene ring; R 2 is a monovalent substituent; R 3 and R 4 are, each independently, a hydrogen atom, C 1-6 alkyl group, or halogen atom; R 5 and R 6 are, each independently, a C 1-6 alkyl group or aryl group; R 7 and R 8 are, each independently, a hydrogen atom, C 1-6 alkyl group, or halogen atom; R 9 and R 10 are, each independently, a hydrogen atom, C 1-6 alkyl group, or monovalent substituent cleaved by contact with a measured substance; R 9 or R 10 optionally forms, together with R 3 or R 7 , a 5-7-member heterocyclyl or heteroaryl containing a nitrogen atom to which R 9 or R 10 binds, and optionally contains 1-3 additional heteroatoms selected from the group consisting of oxygen atoms, nitrogen atoms, and sulfur atoms as rin

Assignees

Inventors

Classifications

  • Dyes containing a substituent, which contains a silicium atom · CPC title

  • Pyronines {; Xanthon, thioxanthon, selenoxanthan, telluroxanthon dyes} · CPC title

  • by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups · CPC title

  • C07F7/0816Primary

    said ring comprising Si as a ring atom · CPC title

  • from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9714260B2 cover?
[Problem] To provide: a compound resulting from substituting with a silicon atom the oxygen atom at position 10 of a xanthene ring site of a rhodamine of which amino groups at position 3 and position 6 have an asymmetrical structure; a method for producing the compound; and a fluorescent probe that uses the compound. [Solution] The compound represented by general formula (I) or a salt the…
Who is the assignee on this patent?
Univ Tokyo
What technology area does this patent fall under?
Primary CPC classification C07F7/0816. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).